Enzyme test for early breast, lung, or pancreatic cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing, Skin clinical trials.
This study tests a new blood test that measures enzyme activity to detect localized cancer. It is for people with newly diagnosed, untreated breast, lung, or pancreatic cancer, as well as healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of localized breast, lung, or pancreatic cancer that has not yet been treated (for the cancer groups).
- You must be scheduled for initial surgery to remove the tumor.
- You must not have received any cancer treatment yet (like chemo, radiation, or immunotherapy).
- You must not have a history of any other cancer (for the control group).
- You cannot be pregnant, breastfeeding, or under legal protection (e.g., minor, prisoner, or adult guardianship).
- You must agree to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study is testing a new blood test that looks for cancer cells in your blood and checks if your tumor has a specific feature linked to DNA repair. The goal is to see if this blood test can help guide whether PARP inhibitor medicines—which target cancers with this feature—might work for you.
This study is testing a new breath test that may help detect cancer by looking for unique chemicals in your breath. It could be a non-invasive way to help diagnose or monitor cancer.
This study looks for cancer-related cells and DNA in samples like blood, urine, and (for some) bone marrow. The goal is to see whether these tests can help detect or track solid cancers with minimal added procedures.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.